These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 18754020

  • 1. Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects.
    Antikainen RL, Grodzicki T, Beevers DG, Webster J, Jokelainen JJ, Bulpitt CJ.
    J Hum Hypertens; 2009 Jan; 23(1):20-6. PubMed ID: 18754020
    [Abstract] [Full Text] [Related]

  • 2. Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?
    Antikainen RL, Grodzicki T, Palmer AJ, Beevers DG, Webster J, Bulpitt CJ, Department of Health and Social Security Hypertension Care Computer Project (DHCCP).
    J Hum Hypertens; 2006 Jun; 20(6):451-9. PubMed ID: 16708082
    [Abstract] [Full Text] [Related]

  • 3. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlöf B, LIFE Study Group.
    Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [Abstract] [Full Text] [Related]

  • 4. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM.
    J Electrocardiol; 2009 Jan; 42(6):584-8. PubMed ID: 19631946
    [Abstract] [Full Text] [Related]

  • 5. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
    Larstorp AC, Okin PM, Devereux RB, Olsen MH, Ibsen H, Dahlöf B, Kjeldsen SE, Wachtell K.
    J Hum Hypertens; 2011 Mar; 25(3):178-85. PubMed ID: 20505749
    [Abstract] [Full Text] [Related]

  • 6. The determinants of left ventricular hypertrophy defined by Sokolow-Lyon criteria in untreated hypertensive patients.
    Antikainen R, Grodzicki T, Palmer AJ, Beevers DG, Coles EC, Webster J, Bulpitt CJ.
    J Hum Hypertens; 2003 Mar; 17(3):159-64. PubMed ID: 12624605
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

  • 11. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES.
    Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients.
    Snelder SM, van de Poll SWE, de Groot-de Laat LE, Kardys I, Zijlstra F, van Dalen BM.
    Clin Cardiol; 2020 May; 43(5):483-490. PubMed ID: 31990994
    [Abstract] [Full Text] [Related]

  • 16. Electrocardiogram Performance in the Diagnosis of Left Ventricular Hypertrophy in Hypertensive Patients With Left Bundle Branch Block.
    Burgos PF, Luna Filho B, Costa FA, Bombig MT, Souza D, Bianco HT, Oliveira Filho JA, Izar MC, Fonseca FA, Póvoa R.
    Arq Bras Cardiol; 2017 Jan; 108(1):47-52. PubMed ID: 27992034
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.